Knotless Tissue Control Devices Market Set to Reach USD 679.8 Mn by 2033

Overview

New York, NY – April 17, 2025 – The Global Knotless Tissue Control Devices Market size is expected to be worth around USD 679.8 Million by 2033 from USD 481.9 Million in 2023, growing at a CAGR of 3.5% during the forecast period from 2024 to 2033.

Advancements in surgical technology have taken a leap forward with the introduction of knotless tissue control devices, a game-changing solution designed to enhance procedural efficiency and improve patient outcomes. These cutting-edge devices eliminate the need for traditional sutures and knots, streamlining surgical procedures and reducing operative time.

Knotless tissue control devices work by anchoring and securing tissue without the complexities of tying knots. By leveraging advanced materials and innovative locking mechanisms, these devices provide consistent tension control, resulting in more precise tissue approximation and reliable wound closure. This not only simplifies the surgeon’s workflow but also reduces the risk of complications associated with improper knots or suture failure.

Already gaining attention in fields such as orthopedics, general surgery, and minimally invasive procedures, knotless tissue control devices are poised to set a new standard in the operating room. Surgeons report improved efficiency, enhanced control, and increased confidence during complex cases, all of which contribute to better patient recovery and satisfaction.

Key Takeaways

• Market Size: The knotless tissue control devices market is projected to grow from USD 481.9 million in 2023 to USD 679.8 million by 2033.
• Market Growth: The market is expected to grow at a compound annual growth rate (CAGR) of 3.5% during the 2024–2033 forecast period.
• Product Analysis: Non-absorbable polymer devices have emerged as the leading product segment, holding a notable 41% share of the market.
• Application Analysis: Hospitals are the primary end-users, representing 42% of the market share due to their central role in performing a wide range of surgical procedures.
• Regional Analysis: North America leads the market with 43.2% of the share, generating USD 208.1 million in revenue, driven by advanced healthcare infrastructure and ongoing technological developments.
• Reduced Complications: These devices have become increasingly popular for their ability to reduce complications during surgical procedures, resulting in better patient outcomes.
• Market Expansion: The market has seen significant growth in product diversity, as manufacturers continue to introduce innovative solutions tailored to various surgical needs.
• Competitive Landscape: Major market players are heavily investing in research and development, fostering strong competition and driving the release of cutting-edge technologies.

Segmentation Analysis

Product Type Analysis: Non-absorbable polymers dominate the knotless tissue control devices market with a 41% share, offering enhanced surgical efficiency. These devices support both short-term procedures, where quick and gentle tissue handling is crucial, and long-term applications requiring durable fixation. Their strength, precision, and biocompatibility have driven widespread adoption, providing reliable outcomes and minimizing tissue trauma. As a result, non-absorbable polymer devices have become integral to modern surgical techniques, benefiting both surgeons and patients alike.

Application Analysis: Hospitals account for 42% of the knotless tissue control devices market, leveraging these devices across diverse surgical specialties. Known for their precision and reliability, they improve operative times and patient outcomes in general, orthopedic, and trauma surgeries. Ambulatory Surgical Centers (ASCs) also adopt these devices for minimally invasive procedures that ensure faster recovery, while trauma centers rely on their quick deployment and dependable performance in urgent situations, showcasing their versatility in various medical settings.

Market Segments

Product Type

• Short-Term
• Long-Term
• Non-Absorbable Polymers

Application

• Hospitals
• Ambulatory Surgical Centers
• Trauma Centers
• Medical Device Manufacturers
• Pharmaceutical Companies
• Others

Regional Analysis

North America holds a commanding 43.2% share of the market, with revenues totaling USD 208.1 million. This dominance is driven by an increasing number of surgical procedures due to rising rates of gynecological and cardiovascular conditions. Additionally, the growing awareness of advanced surgical devices and intensified efforts by industry leaders to gain a foothold in developing countries are further propelling market growth.

Indian Surgical Landscape: In India, about 1,453 surgical procedures are performed annually per 100,000 people, highlighting the significant demand for surgical interventions. This high volume represents a considerable opportunity for medical device manufacturers and healthcare providers to expand their presence in a rapidly growing healthcare market.

Emerging Trends

• Increased Adoption in Robotic Surgeries: The use of knotless tissue control devices, such as barbed sutures, has significantly increased in robotic-assisted surgeries. For instance, their utilization in robotic ventral hernia repair procedures more than doubled from 12.2% to 25.3% between 2015 and 2022. This trend reflects a growing preference for devices that enhance surgical efficiency and reduce operative time.
• Expansion into Neurosurgical Applications: Knotless suturing techniques are being explored for cranial and spinal surgeries, including the closure of cerebrospinal fluid compartments. These applications demonstrate the versatility of knotless devices in managing delicate neural tissues, potentially improving outcomes in neurosurgical procedures.
• Advancements in Biocompatible Materials: Innovations in absorbable and non-absorbable materials have led to the development of knotless devices that offer improved strength and reduced risk of infection. These advancements cater to a broader range of surgical needs, enhancing patient safety and recovery.

Use Cases

• Gynecological Surgeries: In total hysterectomy procedures, the adoption of knotless devices has been associated with a significant reduction in operating room time, averaging 19.1 minutes less compared to traditional suturing methods. This efficiency contributes to cost savings and improved patient throughput.
• Colorectal Surgeries: For colorectal surgeries, patients treated with knotless tissue control devices experienced a 2.8% lower rate of 90-day readmissions compared to those with conventional sutures. This suggests enhanced postoperative outcomes and reduced complications.
• Orthopedic Procedures: In orthopedic surgeries, such as total hip arthroplasty, barbed sutures have been shown to decrease closure time and suture usage, leading to more efficient procedures and potentially faster patient recovery.

Conclusion

In conclusion, the knotless tissue control devices market is witnessing steady growth, fueled by technological advancements, increased surgical efficiency, and improved patient outcomes. With a projected CAGR of 3.5% and expected market value of USD 679.8 million by 2033, these devices are redefining modern surgical practices. Non-absorbable polymers lead the product segment, while hospitals remain the primary end-users.

The growing adoption in robotic and neurosurgical procedures, along with innovations in biocompatible materials, highlight the market’s dynamic evolution. As surgical demands rise globally, knotless tissue control devices are poised to become an essential tool in achieving safer, faster, and more reliable surgical outcomes.